Corporate Spotlight
Not Yet Available
Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.
Latest Threads
Tag | Subject | ||||||
---|---|---|---|---|---|---|---|
1AD | Ann: Investor presentation | 20/05/24 | 8 | 1.1K | |||
|
|||||||
1AD | Ann: SYNThesis BioVentures MoU for cellular immunotherapies | 19/05/24 | 125 | 25K | |||
|
|||||||
1AD | Ann: Application for quotation of securities - 1AD | 17/05/24 | 3 | 952 | |||
|
|||||||
1AD | Ann: Cellular immunotherapy manufacturer secured - Cell Therapies | 13/05/24 | 4 | 1.3K | |||
|
|||||||
1AD | Ann: Application for quotation of securities - 1AD | 13/05/24 | 8 | 2.1K | |||
|
|||||||
1AD | News: 1AD Adalta Says Cell Therapies To Be Preferred Manufacturer Of Cellular Immunotherapies | 13/05/24 | 0 | 132 | |||
|
|||||||
1AD | Ann: Cleansing Notice under Section 708A | 09/05/24 | 0 | 186 | |||
|
|||||||
1AD | Ann: Application for quotation of securities - 1AD | 09/05/24 | 0 | 151 | |||
|
See All Discussions
Timeline
|
|||||
|
|||||
|
|||||
|
|||||
|
|||||
|
|||||
View More |